The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
Sessions will cover process mapping, cost optimisation, data-driven decision-making, cybersecurity, and sustainable manufacturing practices
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
The facility has been classified as Voluntary Action Indicated
Agency initiates safety label change and notifies physicians of possible link
No post-injection Delirium/Sedation Syndrome (PDSS) observed through 56 weeks
Collaboration matches more eligible patients, including those with rare and complex diseases, to appropriate clinical trials
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
Merck opens first climate-neutral manufacturing facility in Ireland
Subscribe To Our Newsletter & Stay Updated
